vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and NewtekOne, Inc. (NEWT). Click either name above to swap in a different company.

NewtekOne, Inc. is the larger business by last-quarter revenue ($73.3M vs $39.9M, roughly 1.8× HARTE HANKS INC). NewtekOne, Inc. runs the higher net margin — 111.8% vs 5.5%, a 106.3% gap on every dollar of revenue. On growth, NewtekOne, Inc. posted the faster year-over-year revenue change (-2.7% vs -15.4%). HARTE HANKS INC produced more free cash flow last quarter ($-686.0K vs $-579.3M). Over the past eight quarters, NewtekOne, Inc.'s revenue compounded faster (12.2% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

NewTek, Inc., is a hardware and software company, based in San Antonio, Texas, that produced live and post-production video tools and visual imaging software for personal computers. The company was founded in 1985 in Topeka, Kansas, United States, by Tim Jenison and Paul Montgomery. On April 1, 2019, it was announced that NewTek would be acquired by Vizrt.

HHS vs NEWT — Head-to-Head

Bigger by revenue
NEWT
NEWT
1.8× larger
NEWT
$73.3M
$39.9M
HHS
Growing faster (revenue YoY)
NEWT
NEWT
+12.7% gap
NEWT
-2.7%
-15.4%
HHS
Higher net margin
NEWT
NEWT
106.3% more per $
NEWT
111.8%
5.5%
HHS
More free cash flow
HHS
HHS
$578.7M more FCF
HHS
$-686.0K
$-579.3M
NEWT
Faster 2-yr revenue CAGR
NEWT
NEWT
Annualised
NEWT
12.2%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HHS
HHS
NEWT
NEWT
Revenue
$39.9M
$73.3M
Net Profit
$2.2M
$19.5M
Gross Margin
Operating Margin
-0.3%
Net Margin
5.5%
111.8%
Revenue YoY
-15.4%
-2.7%
Net Profit YoY
6.6%
EPS (diluted)
$0.30
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
NEWT
NEWT
Q4 25
$39.9M
$73.3M
Q3 25
$39.5M
$74.9M
Q2 25
$38.6M
$70.2M
Q1 25
$41.6M
$66.3M
Q4 24
$47.1M
$75.4M
Q3 24
$47.6M
$62.8M
Q2 24
$45.0M
$61.1M
Q1 24
$45.4M
$58.3M
Net Profit
HHS
HHS
NEWT
NEWT
Q4 25
$2.2M
$19.5M
Q3 25
$-2.3M
$17.9M
Q2 25
$-335.0K
$13.7M
Q1 25
$-392.0K
$9.4M
Q4 24
$18.3M
Q3 24
$142.0K
$11.9M
Q2 24
$-27.8M
$10.9M
Q1 24
$-171.0K
$9.7M
Operating Margin
HHS
HHS
NEWT
NEWT
Q4 25
-0.3%
Q3 25
1.3%
Q2 25
0.1%
Q1 25
-0.1%
Q4 24
-3.3%
Q3 24
4.0%
Q2 24
3.0%
Q1 24
0.8%
Net Margin
HHS
HHS
NEWT
NEWT
Q4 25
5.5%
111.8%
Q3 25
-5.8%
23.9%
Q2 25
-0.9%
19.5%
Q1 25
-0.9%
14.1%
Q4 24
24.3%
Q3 24
0.3%
19.0%
Q2 24
-61.8%
17.9%
Q1 24
-0.4%
16.6%
EPS (diluted)
HHS
HHS
NEWT
NEWT
Q4 25
$0.30
$0.64
Q3 25
$-0.31
$0.67
Q2 25
$-0.05
$0.52
Q1 25
$-0.05
$0.35
Q4 24
$-0.31
$0.70
Q3 24
$0.02
$0.45
Q2 24
$-3.84
$0.43
Q1 24
$-0.02
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
NEWT
NEWT
Cash + ST InvestmentsLiquidity on hand
$5.6M
Total DebtLower is stronger
$819.9M
Stockholders' EquityBook value
$20.5M
$397.6M
Total Assets
$91.8M
$2.7B
Debt / EquityLower = less leverage
2.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
NEWT
NEWT
Q4 25
$5.6M
Q3 25
$6.5M
Q2 25
$4.8M
Q1 25
$9.0M
Q4 24
$9.8M
Q3 24
$5.9M
Q2 24
$11.0M
Q1 24
$11.5M
Total Debt
HHS
HHS
NEWT
NEWT
Q4 25
$819.9M
Q3 25
$748.5M
Q2 25
$657.3M
Q1 25
$774.0M
Q4 24
$708.0M
Q3 24
$655.8M
Q2 24
$652.0M
Q1 24
$662.5M
Stockholders' Equity
HHS
HHS
NEWT
NEWT
Q4 25
$20.5M
$397.6M
Q3 25
$19.9M
$386.7M
Q2 25
$22.2M
$312.2M
Q1 25
$21.4M
$302.3M
Q4 24
$21.7M
$296.3M
Q3 24
$21.0M
$281.8M
Q2 24
$20.6M
$274.0M
Q1 24
$20.0M
$254.1M
Total Assets
HHS
HHS
NEWT
NEWT
Q4 25
$91.8M
$2.7B
Q3 25
$92.7M
$2.4B
Q2 25
$95.0M
$2.1B
Q1 25
$100.6M
$2.1B
Q4 24
$101.8M
$2.1B
Q3 24
$108.1M
$1.7B
Q2 24
$109.7M
$1.6B
Q1 24
$113.4M
$1.5B
Debt / Equity
HHS
HHS
NEWT
NEWT
Q4 25
2.06×
Q3 25
1.94×
Q2 25
2.11×
Q1 25
2.56×
Q4 24
2.39×
Q3 24
2.33×
Q2 24
2.38×
Q1 24
2.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
NEWT
NEWT
Operating Cash FlowLast quarter
$737.0K
$-579.2M
Free Cash FlowOCF − Capex
$-686.0K
$-579.3M
FCF MarginFCF / Revenue
-1.7%
-790.0%
Capex IntensityCapex / Revenue
3.6%
0.1%
Cash ConversionOCF / Net Profit
0.33×
-29.64×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M
$-1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
NEWT
NEWT
Q4 25
$737.0K
$-579.2M
Q3 25
$3.2M
$-167.3M
Q2 25
$-4.8M
$-199.8M
Q1 25
$-818.0K
$-60.7M
Q4 24
$4.0M
$-153.0M
Q3 24
$-2.9M
$-25.7M
Q2 24
$1.6M
$2.9M
Q1 24
$-5.7M
$-38.7M
Free Cash Flow
HHS
HHS
NEWT
NEWT
Q4 25
$-686.0K
$-579.3M
Q3 25
$2.2M
$-167.3M
Q2 25
$-5.1M
$-199.9M
Q1 25
$-923.0K
$-60.7M
Q4 24
$3.4M
$-153.5M
Q3 24
$-4.9M
$-25.9M
Q2 24
$926.0K
$2.9M
Q1 24
$-6.2M
$-38.7M
FCF Margin
HHS
HHS
NEWT
NEWT
Q4 25
-1.7%
-790.0%
Q3 25
5.5%
-223.3%
Q2 25
-13.1%
-284.7%
Q1 25
-2.2%
-91.6%
Q4 24
7.3%
-203.6%
Q3 24
-10.2%
-41.2%
Q2 24
2.1%
4.7%
Q1 24
-13.7%
-66.5%
Capex Intensity
HHS
HHS
NEWT
NEWT
Q4 25
3.6%
0.1%
Q3 25
2.5%
0.0%
Q2 25
0.6%
0.1%
Q1 25
0.3%
0.1%
Q4 24
1.3%
0.6%
Q3 24
4.0%
0.4%
Q2 24
1.5%
0.1%
Q1 24
1.2%
0.1%
Cash Conversion
HHS
HHS
NEWT
NEWT
Q4 25
0.33×
-29.64×
Q3 25
-9.35×
Q2 25
-14.58×
Q1 25
-6.48×
Q4 24
-8.35×
Q3 24
-20.76×
-2.15×
Q2 24
0.27×
Q1 24
-4.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

NEWT
NEWT

Segment breakdown not available.

Related Comparisons